There were no double-digit losers this week, and lots os small gains, however a big chunk of the recovery came from the double-digit risers. KIBO:Kibo Mining climbed 11% but is still making an overall loss. It did have a very positive impact on the paper losses though.
Share of the Week is IQE:IQE, which climbed 14% and every time I think it's run out of steam, the price carries on rising. The ISA holding is now 120% up on when I bought at 29.6p, with a bid price of 65.75p.
Hopefully nothing horrid will happen next week and we can get back in the black.
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,556.91 | -£19.74 | |
| Portfolio sell value (bid price - commission) | £40,970.22 | (-3.7%) | +£1,019.32 |
| Potential profits | £4,052.42 | +£547.17 | |
| Yr 2 Dividends | £365.04 | +£0 | |
| Yr 2 Profit from sales | £2,401.06 | -£23.37 | |
| Yr 2 Average monthly cash profit | £296.00 | -£10.61 | |
| Yr 2 Avg annual % of current portfolio cost | 8.3% | ||
| Total Dividends | £1,032.97 | +£0 | |
| Total Profit from sales | £6.241.32 | -£23.37 | |
| Average monthly cash profit | £338.20 | -£5.01 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.5% |
The small drop in cost was due to making a small loss of £23.37 selling TW.:Taylor Wimpey, which was offset by the dividends. The proceeds were all re-invested in OPTI:Optibiotix which ended up by just 1p from last week, but the new shares were bought 1.5p cheaper than that price, so are already contributing towards reducing the Optibiotix losses. Portfolio value up by £1,019, of which about half was increased profit (mainly IQE:IQE) and half was reduced losses (mainly KIBO:Kibo Mining). No dividends so performance drops a little more than usual, and profits of 9.5% are 0.5% below my target, so I need to consider how best to rectify that.
Nice to see the green line going in the right direction again after a few torrid weeks.
The SIPP looks like this after week 76
| Weekly Change | |||
| Portfolio cost | £17,468.71 | -£28.15 | |
| Portfolio sell value (bid price - commission) | £19,041.57 | (+9.0%) | +£110.27 |
| Potential profits | £2,634.36 | +£8.03 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£69.26 | |
| Yr 2 Average monthly cash profit | £280.57 | +£0.86 | |
| Yr 2 Avg annual % of current portfolio cost | 19.3% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,946.67 | +£69.26 | |
| Average monthly cash profit | £243.25 | +£0.76 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 16.7% |
The cost dropped because when I tried to re-invest the proceeds from selling some JLP:Jubilee Platinum in OPTI:Optibiotix I had to leave a limit order and was expecting to pay 66p but ended up paying 64.28p stranding some cash in my account. Overall a very quiet week, with an increase in value of just £110, but there's also the £69.26 profit taken. The effect on performance was negligible. Instead of the usual drops, performance improved by just 86p a month for year 2 and 76p a month overall.
Just need the two lines to start repelling each other and move apart.
The trading account looks like this after week 42
| Weekly Change | |||
| Portfolio cost | £986.03 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £877.62 | (-11.0%) | +£72.48 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£2.36 | +£0.06 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | -2.9% |
KIBO:Kibo Mining had a good week, so things are on the mend. So far this excercise is just proving the point that day trading is really hard, especially when you're not prepared to take a loss and end up stuck with shares for months. Having this sacrificial account is great though, as it allows me to focus my other accounts on long term investments without tempation to trade.
That's looking a little more promising now.
I was feeliong quite rebellious this week, mainly down to the strife with OPTI:Optibiotix appearing to be attacked, and I believe the same thing was happening to KIBO:Kibo Mining, although the main troll on their bulletin board was just a plain dickhead and I suspect too thick to be involved in shorting. He could have been taking cash from someone to spout gibberish on the bulletin board though. His attempts to post on half a dozen threads in order to hide the main thread seem to have failed miserbly, and it's pleasing that Kibo has recovered so well this week. With KAT:Katoro Mining listing from the reverse takeover of OPRA:Opera Investments on 23rd May, an announcement on share distribution to Kibo holders should see the price sneak a bit higher.
OPTI:Optibiotix had a great end to the week. If the shares were under attack, it's possible that is over, although a new troll has appeared on the bulletin board today, so it may be a while before things settle down. Each 1p recovery is now worth over £200, and the price needed to get back into profit is a few pence lower thanks to the 64p puchases this week. The best possible news next week would be the announcement of how SBTX:SkinBiotherapeutics shares are to be distributed amongst Optibiotix holders, and news on sales of LPLDL® following last week's launch and opportunity to do deals at the Vitafoods show alongside new partners Nutrilinea.
No comments:
Post a Comment